The Pharma Legal Handbook: Croatia

Croatia is a European Union member state with a pharmaceutical regulatory framework administered by HALMED, the Agency for Medicinal Products and Medical Devices. Since EU accession, Croatia's regulatory environment has aligned closely with EU standards, and HALMED participates actively in EMA procedures, making it an important market for companies managing pan-European registration strategies.

Croatia's reimbursement system operates through the Croatian Health Insurance Fund (HZZO), which maintains a positive list for reimbursable products. The process for gaining reimbursement listing involves a health technology assessment and price negotiation process that companies need to navigate with an understanding of local priorities and decision-making timelines.

The Pharma Legal Handbook: Croatia provides comprehensive guidance on pharmaceutical regulation in Croatia, covering product authorisation, HZZO reimbursement pathways, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, parallel imports, and intellectual property protection.

If legal handbook content is updated, you will receive an updated PDF free for up to one year after purchase.